ASMB peer analysis
Assembly Biosciences (ASMB) against its competitors: price, today's move, 1-year return and market value side by side.
ASMB and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ABUS Arbutus Biopharma | $3.65 | -10.10% | -18.89% | $804.31M |
| ALGS Aligos Therapeutics | $5.02 | 5.68% | -39.15% | – |
| AVIR Atea Pharmaceuticals | $4.21 | -5.61% | 31.15% | – |
| COCP Cocrystal Pharma | $1.01 | -5.61% | -7.34% | $19.46M |
| ENTA Enanta Pharmaceuticals | $10.11 | -5.07% | -6.48% | $310.19M |
| INDP Indaptus Therapeutics | $3.30 | 1.85% | 16.20% | – |
| VIR Vir Biotechnology | $10.95 | -6.97% | 108.57% | $1.99B |
| ASMB Assembly Biosciences | $19.94 | 0.35% | -36.56% | $404.57M |
- ASMB's peers: ABUS (Arbutus Biopharma), ALGS (Aligos Therapeutics), AVIR (Atea Pharmaceuticals), COCP (Cocrystal Pharma), ENTA (Enanta Pharmaceuticals), INDP (Indaptus Therapeutics), VIR (Vir Biotechnology).
Updated 2026-11-06 11:42 UTC